Walgreens Partners to Expand Colorectal Cancer Screening Access
The initiative gives eligible pharmacy customers a streamlined pathway to request the Cologuard stool DNA test, with no prep or special diet required.
Read MorePosted by CLP Edit Staff | Mar 13, 2026 | Colorectal |
The initiative gives eligible pharmacy customers a streamlined pathway to request the Cologuard stool DNA test, with no prep or special diet required.
Read MorePosted by CLP Edit Staff | Mar 13, 2026 | Diagnostic Technologies |
The handheld system supports point-of-care fractional exhaled nitric oxide testing in adults and pediatric patients.
Read MorePosted by CLP Edit Staff | Mar 13, 2026 | Cancer |
Hepion Pharmaceuticals has licensed a circulating tumor RNA assay from Cirna Diagnostics for early detection of hepatocellular carcinoma in high-risk patients, expanding its liquid biopsy portfolio for liver cancer.
Read MorePosted by CLP Edit Staff | Mar 12, 2026 | Molecular Diagnostics |
Baylor Genetics has added optical genome mapping and long-read sequencing to its whole genome sequencing test, expanding STR analysis, enabling FMR1 methylation detection, and improving structural variant interpretation.
Read MorePosted by CLP Edit Staff | Mar 9, 2026 | Analytical Software Systems |
Droplet Biosciences reports reducing genomic analysis time from days to hours for its LymphDetect test by adopting NVIDIA Parabricks GPU-accelerated software.
Read More